Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

ZEB1: Catalyst of immune escape during tumor metastasis
Jiahui Lü, Fei Fei, Chenxi Wu, et al.
Biomedicine & Pharmacotherapy (2022) Vol. 153, pp. 113490-113490
Open Access | Times Cited: 22

Showing 22 citing articles:

Unveiling the mechanisms and challenges of cancer drug resistance
Sameer Ullah Khan, Kaneez Fatima, Shariqa Aisha, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 101
Transcending frontiers in prostate cancer: the role of oncometabolites on epigenetic regulation, CSCs, and tumor microenvironment to identify new therapeutic strategies
Giulia Ambrosini, Marco Cordani, Ali Zarrabi, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 12
MicroRNA‐431‐5p inhibits angiogenesis, lymphangiogenesis, and lymph node metastasis by affecting TGF‐β1/SMAD2/3 signaling via ZEB1 in gastric cancer
Pengpeng Liu, Pingan Ding, Jiaxuan Yang, et al.
Molecular Carcinogenesis (2024) Vol. 63, Iss. 7, pp. 1378-1391
Closed Access | Times Cited: 5
An "unexpected" role for EMT transcription factors in hematological development and malignancy
Karthika Radhakrishnan, Lynda Truong, Catherine Carmichael
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 11
A single-cell atlas characterizes dysregulation of the bone marrow immune microenvironment associated with outcomes in multiple myeloma
William C. Pilcher, Lijun Yao, Edgar Gonzalez‐Kozlova, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access | Times Cited: 4
Biomarkers for the detection of circulating tumor cells
Karol Gostomczyk, Magdalena Drozd, Mohammed Dheyaa Marsool Marsool, et al.
Experimental Cell Research (2025) Vol. 448, Iss. 1, pp. 114555-114555
Closed Access
Dualistic role of ZEB1 and ZEB2 in tumor progression
Sergey Parfenyev, Alexandra Daks, Oleg Shuvalov, et al.
Biology Direct (2025) Vol. 20, Iss. 1
Open Access
ERK2-mediated phosphorylation of ZEB1 at S322 enhances PD-L1 expression and EMT, leading to pancreatic cancer progression
Mi Kyung Park, Hye Ja Lee, Jee Young Sung, et al.
Cell Communication and Signaling (2025) Vol. 23, Iss. 1
Open Access
Genome-wide DNA methylation analysis of Astragalus on the intervention of ID2 promoter via PI3K/Akt signaling pathway in peritoneal fibrosis
Manshu Yu, Junyi Zhao, Yun Shan, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Dual role of Snail1 as transcriptional repressor and activator
Antonio Garcı́a de Herreros
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2023) Vol. 1879, Iss. 1, pp. 189037-189037
Closed Access | Times Cited: 8
miR-34b-5p suppresses the epithelial-mesenchymal transition and metastasis in endometrial cancer AN3CA cells by targeting ZEB1
Lulu Shi
International Journal of Clinical and Experimental Pathology (2024) Vol. 17, Iss. 4, pp. 137-150
Open Access | Times Cited: 3
TRIM58 Interacts with ZEB1 to Suppress NSCLC Tumor Malignancy by Promoting ZEB1 Protein Degradation via UPP
Rongxin Shang, Jiakuan Chen, Yang Gao, et al.
Disease Markers (2023) Vol. 2023, pp. 1-13
Open Access | Times Cited: 7
CD73 mitigates ZEB1 expression in papillary thyroid carcinoma
Samlai Vedovatto, Fernanda Dittrich Oliveira, Luiza C. Pereira, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Angiogenesis and EMT regulators in the tumor microenvironment in lung cancer and immunotherapy
Taotao Yan, Jiahai Shi
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
TRIM9 Interacts with ZEB1 to Suppress Esophageal Cancer by Promoting ZEB1 Protein Degradation via the UPP Pathway
Zhaoxian Lin, Jianyuan Huang, Lihuan Zhu, et al.
BioMed Research International (2023) Vol. 2023, Iss. 1
Open Access | Times Cited: 5
Long Non-Coding RNAs as Epigenetic Regulators of Immune Checkpoints in Cancer Immunity
Wiam Saadi, Ahlam Fatmi, Federico V. Pallardó, et al.
Cancers (2022) Vol. 15, Iss. 1, pp. 184-184
Open Access | Times Cited: 8
Altered Phenotypes of Breast Epithelial × Breast Cancer Hybrids after ZEB1 Knock-Out
Alexander Merckens, Mareike Sieler, Silvia Keil, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 24, pp. 17310-17310
Open Access | Times Cited: 4
Zeb1 maintains long-term adult hematopoietic stem cell function and extramedullary hematopoiesis
Alhomidi Almotiri, Ali Abdelfattah, E.K. Storch, et al.
Experimental Hematology (2024) Vol. 134, pp. 104177-104177
Open Access | Times Cited: 1
ZEB family is a prognostic biomarker and correlates with anoikis and immune infiltration in kidney renal clear cell carcinoma
Lin Sheng, Qi Chen, Canliang Tan, et al.
BMC Medical Genomics (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 1
Cisplatin Disrupts Proteasome Bounce-Back Effect through Suppressing ZEB1/Nfe2l1 in Cholangiocarcinoma
Yuancai Xiang, Man Jia, Yuan Gao, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 3
Open Access | Times Cited: 1
ZEB1 as a marker of metastasis in thyroid carcinomas: review of literature and own data
P. P. Zinych, V.M. Pushkarev, Н.І. Левчук, et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine) (2024) Vol. 20, Iss. 7, pp. 517-528
Open Access
A expressão dos marcadores de transição epitélio-mesenquimal SNAI1 e o ZEB1 resulta em alterações transcricionais para promover progressão tumoral e evasão imune no câncer de próstata
Luiz Paulo Chaves
(2023)
Open Access
miR-186 regulates epithelial–mesenchymal transformation to promote nasopharyngeal carcinoma metastasis by targeting ZEB1
Liangke Tang, Ya-Lang Xiang, Zhou Jing, et al.
Brazilian Journal of Otorhinolaryngology (2023) Vol. 90, Iss. 1, pp. 101358-101358
Open Access
Page 1

Scroll to top